APLN and alkaline phosphatase measurement: In this pathological context, apelin treatment reduces AP- and CP-induced elevations of NF-κB activation in the pancreas and so decreases the inflammatory as well as fibrosis responses by reducing neutrophil recruitment and pancreatic stellate cells activity [19,20].